Evidence map›Paper›PMID 34309892›Full record

ArticleClinical and experimental dermatology2022

Dupilumab in adolescents with moderate to severe atopic dermatitis: a 32-week real-world experience during the COVID-19 pandemic.

K Hansel, C Patruno, E Antonelli, G Dal Bello, M Napolitano, G Fabbrocini, T Grieco, G Pellacani, M C Fargnoli, M Esposito and 4 more

Open access · greenAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical and experimental dermatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Allergic diseases and immunodeficiencies in children, lessons learnt from COVID-19 pandemic by 2022: A statement from the EAACI-section on pediatrics.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2022
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 8 institutions in 1 country.

K HanselDermatology Section, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
C PatrunoSection of Dermatology, Health Sciences Department, Magna Graecia University, Catanzaro, Italy.
E AntonelliDermatology Section, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
G Dal BelloSection of Dermatology and Venereology, Department of Medicine, University of Verona, Verona, Italy.ORCID 0000-0002-5645-8403
M NapolitanoDepartment of Medicine and Health Sciences Vincenzo Tiberio, University of Molise, Campobasso, Italy.ORCID 0000-0003-3309-8190
G FabbrociniSection of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
T GriecoDermatology Unit, Sapienza University of Rome, Rome, Italy.
G PellacaniDermatology Unit, Sapienza University of Rome, Rome, Italy.
M C FargnoliDermatology, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.ORCID 0000-0002-7249-2556
M EspositoDermatology, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
V PirasDermatological Clinic, Department of Medical Science and Public Health, University of Cagliari, Cagliari, Italy.
M ZuccaDermatological Clinic, Department of Medical Science and Public Health, University of Cagliari, Cagliari, Italy.
G GirolomoniSection of Dermatology and Venereology, Department of Medicine, University of Verona, Verona, Italy.
L StingeniDermatology Section, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.ORCID 0000-0001-7919-8141
University of Perugia · ITSapienza University of Rome · ITUniversity of Cagliari · ITUniversity of L'Aquila · ITUniversity of Verona · ITMagna Graecia University · ITUniversity of Molise · ITUniversity of Naples Federico II · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdolescentAntibodies, Monoclonal, HumanizedCOVID-19Dermatitis, AtopicFemaleHumansItalyMaleProspective StudiesTreatment OutcomeAntibodies, Monoclonal, Humanizeddupilumab

Identifiers

PMID34309892
PMCPMC8444687
OpenAlexW3185917076

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.